Skip to main content
Safe S.A. logo

Safe S.A. — Investor Relations & Filings

Ticker · ALSAF ISIN · FR001400F1V2 LEI · 969500DG8YK9AV60FN03 Euronext Growth Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2022-02-21 Regulatory Filings
Country FR France
Listing Euronext Growth ALSAF

About Safe S.A.

https://www.safeorthopaedics.com/

Safe S.A., operating through its Safe Metal division, is a company specializing in the co-design and production of cast steel components. Utilizing green sand casting processes, the company manufactures essential parts for various industrial applications. Safe Metal positions itself as a world leader in its field, collaborating with clients to develop and supply critical components.

Recent filings

Filing Released Lang Actions
Safe Orthopaedics announces the signature of an agreement with Brainlab for the development of navigation for Safe Orthopaedics instruments
Regulatory Filings Classification · 1% confidence The document is a press release dated February 21, 2022, announcing a strategic development agreement between Safe Orthopaedics and Brainlab regarding navigation technology for surgical instruments. This type of announcement, detailing a partnership, business development, or strategic move that is not a mandatory periodic financial filing (like 10-K or IR) or a specific corporate action (like dividend or share issue), typically falls under general corporate news. Since there is no specific category for 'Partnership Announcement' or 'Business Update,' and it is not a transcript, management discussion, or formal financial report, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for significant, non-standard corporate announcements released to the public/market.
2022-02-21 English
Safe Orthopaedics annonce la signature d’un accord avec la société Brainlab pour le développement de la navigation des instruments Safe Orthopaedics
Regulatory Filings Classification · 1% confidence The document announces a strategic development agreement between Safe Orthopaedics and Brainlab regarding medical instrument navigation. This is a corporate announcement detailing a partnership and future business strategy, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). It is a general business update. Since there is no specific category for 'Partnership Announcement' or 'Strategic Agreement,' and it is not a management change (MANG) or a capital event (CAP), it falls best under the general regulatory/corporate announcement category, which is RNS (Regulatory Filings), as it is a significant, non-standard corporate disclosure.
2022-02-21 French
Safe group annonce un chiffre d’affaires annuel consolidé de 4,6M€ en hausse de 23%
Earnings Release Classification · 1% confidence The document is a press release dated January 13, 2022, announcing the company's consolidated annual revenue (chiffre d'affaires annuel) for the full year 2021. It provides detailed financial tables comparing 2021 results to 2020, discusses business segments (Safe Orthopaedics and Safe Medical), and mentions the cash position as of 12/31/2021. This content structure—a summary of full-year financial performance released shortly after the year-end—is characteristic of an Earnings Release (ER), which typically precedes the comprehensive Annual Report (10-K). Since it focuses on the 'chiffre d'affaires annuel' and key financial highlights for the period, ER is the most appropriate classification, rather than the full 10-K or a quarterly report (IR). FY 2021
2022-01-13 French
Safe group announces consolidated annual sales of €4.6M, up 23%
Earnings Release Classification · 1% confidence The document explicitly announces the company's "2021 annual revenue and its cash position" and provides detailed consolidated sales figures for the 12 months ending in 2021. This content structure—presenting full-year financial performance highlights immediately following the year-end—is characteristic of an Earnings Release (ER). While it covers the full year, it is presented as a press release summarizing key figures (€4.6M sales, up 23%) rather than the comprehensive, audited filing (10-K) or the detailed management discussion (MDA). It is too detailed for a simple Report Publication Announcement (RPA) and focuses on results, not just the announcement of results. Therefore, Earnings Release (ER) is the most appropriate classification. FY 2021
2022-01-13 English
Safe Orthopaedics announces first clinical benefits at 3 months and global launch of Sycamore
Regulatory Filings Classification · 1% confidence The document is an announcement from Safe Orthopaedics detailing clinical benefits (3-month follow-up results showing 65% pain reduction) for their Sycamore product and announcing its global launch in January 2022. It includes quotes from surgeons and the CEO, focusing on product performance and commercial rollout. This content is characteristic of an Earnings Release (ER) or a general business update, but since it is not a formal quarterly financial report (like an IR or 10-K) and focuses on operational/product news rather than just financial highlights, it fits best as a general business announcement. Given the options, it is a specific operational update that doesn't fit the strict definitions of ER (which usually focuses on P&L/Balance Sheet figures) or CT. However, since it announces key operational achievements and commercial plans, it is most closely aligned with an Earnings Release (ER) which often includes operational highlights alongside financial metrics, or potentially a Regulatory Filing (RNS) if it were a mandatory disclosure. Since it is a proactive announcement of positive clinical data and launch plans, ER is a strong candidate if it's tied to a reporting period, but as a standalone product/clinical update, it functions as a general business announcement. Given the context of financial reporting databases, announcements of clinical milestones and commercial launches often fall under ER or RNS. Since it is a detailed announcement of operational progress rather than just a brief financial summary, and it is not a formal regulatory filing like a 10-K or IR, I will classify it as an Earnings Release (ER) as these often contain operational achievements, or RNS as a general announcement. Given the focus on clinical benefits and launch, it reads like a press release accompanying or preceding a financial report. I will select ER as it contains performance metrics (pain reduction) and future outlook, which are common in ERs, even if the core financial tables are missing. If it were purely regulatory, RNS would be better. Since it is a performance update, ER is the most fitting specific category.
2021-12-20 English
Safe Orthopaedics annonce les premiers bénéfices cliniques à 3 mois et le lancement mondial de Sycamore
Earnings Release Classification · 1% confidence The document is titled "Safe Orthopaedics annonce les premiers bénéfices cliniques à 3 mois et le lancement mondial de Sycamore" and is dated December 20, 2021. It details positive clinical evaluation results (pain reduction) for a product (Sycamore) and announces its worldwide commercial launch starting in January 2022. This content structure—announcing key operational/clinical milestones and commercial plans, often issued as a press release—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it focuses on operational achievements and future commercialization rather than detailed periodic financial statements (like 10-K or IR) or management discussion (MDA), and it is a formal announcement, it fits best as an Earnings Release (ER) which typically covers key operational highlights for a period, even if it's not strictly quarterly results. Given the context of announcing clinical success and a product launch, ER is the most appropriate specific code over the general RNS. FY 2021
2021-12-20 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.